Literature DB >> 15669091

Selection of high-producing CHO cells using NPT selection marker with reduced enzyme activity.

Kerstin Sautter1, Barbara Enenkel.   

Abstract

We developed an expression system that aimed to increase the proportion of high producers in a transfected cell population in order to reduce the effort in clone screening. The principle is based on the impairment of the selection marker. Twelve single-point mutations in more or less conserved domains of the resistance marker gene neomycin-phosphotransferase (NPT) resulted in different degrees of reduced enzyme activity, depending on the amino acid conservation and the kind of amino acid exchange. In all transfected, mutant-NPT bearing CHO-DG44 cell pools surviving the selection with G418, the ratio of high-producing cells to total cell number was higher than in pools selected with wildtype-NPT. Furthermore, these pools showed, in comparison to wildtype-NPT selected pools, not only higher NPT-RNA levels but also increased specific productivities and higher titers of a coexpressed biopharmaceutically relevant product. Elevated productivity could be ascribed to higher gene copy numbers, integration into chromatin regions with higher transcriptional activity, or a combination of both effects. Thus, the use of NPT-mutants as selection markers is suitable for the enrichment of high producers in a transfected CHO-DG44 cell population, since cell survival is achieved only if the enzymatic impairment of the cointegrated resistance marker is compensated by a higher expression level. 2005 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15669091     DOI: 10.1002/bit.20374

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  9 in total

1.  Transcriptome and proteome profiling to understanding the biology of high productivity CHO cells.

Authors:  Peter Morin Nissom; Arleen Sanny; Yee Jiun Kok; Yeo Thong Hiang; Song Hui Chuah; Tan Kher Shing; Yih Yean Lee; Kathy Tin Kam Wong; Wei-Shou Hu; Miranda Yap Gek Sim; Robin Philp
Journal:  Mol Biotechnol       Date:  2006-10       Impact factor: 2.695

Review 2.  Recent advances in mammalian protein production.

Authors:  Ashok D Bandaranayake; Steven C Almo
Journal:  FEBS Lett       Date:  2013-12-06       Impact factor: 4.124

Review 3.  Screening Strategies for High-Yield Chinese Hamster Ovary Cell Clones.

Authors:  Wenwen Yang; Junhe Zhang; Yunxi Xiao; Wenqing Li; Tianyun Wang
Journal:  Front Bioeng Biotechnol       Date:  2022-06-17

4.  Stabilizing and Anti-Repressor Elements Effectively Increases Transgene Expression in Transfected CHO Cells.

Authors:  Qin Li; Rui-Fang Yan; Yong-Xiao Yang; Chun-Liu Mi; Yan-Long Jia; Tian-Yun Wang
Journal:  Front Bioeng Biotechnol       Date:  2022-05-26

5.  Impact of using different promoters and matrix attachment regions on recombinant protein expression level and stability in stably transfected CHO cells.

Authors:  Steven C L Ho; Jessna H M Yeo; Shiyi Goh Fang; Yuansheng Yang
Journal:  Mol Biotechnol       Date:  2015-02       Impact factor: 2.695

6.  Methods to create a stringent selection system for mammalian cell lines.

Authors:  H J M Van Blokland; F Hoeksema; M Siep; A P Otte; J A Verhees
Journal:  Cytotechnology       Date:  2011-04-21       Impact factor: 2.058

7.  Engineering selection stringency on expression vector for the production of recombinant human alpha1-antitrypsin using Chinese Hamster ovary cells.

Authors:  Christine Lin Chin; Hing Kah Chin; Cara Sze Hui Chin; Ethan Tingfeng Lai; Say Kong Ng
Journal:  BMC Biotechnol       Date:  2015-06-02       Impact factor: 2.563

8.  Advances in Mammalian cell line development technologies for recombinant protein production.

Authors:  Tingfeng Lai; Yuansheng Yang; Say Kong Ng
Journal:  Pharmaceuticals (Basel)       Date:  2013-04-26

9.  Evaluating the use of a CpG free promoter for long-term recombinant protein expression stability in Chinese hamster ovary cells.

Authors:  Steven C L Ho; Esther Y C Koh; Benjamin P C Soo; Sheng-Hao Chao; Yuansheng Yang
Journal:  BMC Biotechnol       Date:  2016-10-18       Impact factor: 2.563

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.